Boston Scientific - Femoropopliteal stents

Are all femoropopliteal stents performing the same?

New meta-analysis comparing femoropopliteal stents

141 studies | 35,897 patients | 4 stent types

‘Performance of stenting in femoropopliteal disease: Systematic review and meta-analysis of proportions’

Download article

The stent types analyzed*:

A polymer-based paclitaxel-eluting stent - ELUVIA™
A polymer-free paclitaxel-coated stent - Zilver® PTX®
A covered stent - GORE® VIABAHN® VBX
Bare metal stents (BMS)

Key outcomes at 12 and 24 months

Across pooled data, polymer-based paclitaxel-eluting stent showed:

Higher Primary Patency (PP) at 1 year

Eluvia DES showed the highest PP pooled rates across all lesion lengths, with differences even more pronounced in long lesions.

Lower TLR rates at 2 years

No detectable difference in all-cause mortality between paclitaxel-based and non–drug-coated devices.

Want to see more?

The full article is available online:

Download now

Boston Scientific International SA

www.bostonscientific.eu | Tel: +33 1 39 30 97 00

Parc Val Saint Quentin - Bâtiment H | 2 Rue René Caudron | 78960 Voisins-le-Bretonneux

VAT: FR07420668402

References

1. Gouëffic, Y., Bosworth Smith, A., Distler, F., Lissina, A., Hafermann, J., Saunders, R., Holden, A., & Steiner, S. (2026). Performance of stenting in femoropopliteal disease: A systematic literature review and meta-analysis of proportions. Journal of Comparative Effectiveness Research, e250152. https://doi.org/10.57264/cer-2025-0152

*Study design
Pooled analysis of 141 PubMed articles (2009-2024; n=35,897 SFA/PAD stent patients, ≥50 per study).

Evaluated primary patency, TLR, and mortality at 12 and 24 months, with subgroup analysis for lesion length.

CAUTION

The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.
This material is not intended for use in France.

PI-2458601-AA
CⲈ 0344

Privacy Policy | Terms of Use

For questions on privacy
Contact our EU Data Protection Officer at: [email protected]
Boston Scientific
c/Ribera del Loira, 46 Edificio 2
28042 Madrid (Spain)